{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:59:34Z","timestamp":1790830774466,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cell Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejcb.2026.151565","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:06:46Z","timestamp":1787209606000},"page":"151565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TCF3 safeguards tumor-intrinsic interferon competence to restrain prostate cancer progression and immune escape"],"prefix":"10.1016","volume":"105","author":[{"given":"Shengjie","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-7404","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-Hong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ejcb.2026.151565_bib1","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ejcb.2026.151565_bib2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2013.04.014","article-title":"A genetic screen identifies TCF3\/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation","volume":"3","author":"Andrysik","year":"2013","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-021-00249-2","article-title":"Prostate cancer.","volume":"7","author":"ANON","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10","key":"10.1016\/j.ejcb.2026.151565_bib4","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1158\/1078-0432.CCR-23-2438","article-title":"Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series","volume":"30","author":"Anselmino","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ejcb.2026.151565_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1074-7613(00)80421-5","article-title":"Both E12 and E47 allow commitment to the B cell lineage","volume":"6","author":"Bain","year":"1997","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ejcb.2026.151565_bib6","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20090756","article-title":"Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci","volume":"206","author":"Beck","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib8","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1038\/s41467-021-26840-5","article-title":"Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression","volume":"12","author":"Bolis","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","article-title":"An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance","volume":"19","author":"Byers","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI66666","article-title":"ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer","volume":"123","author":"Cai","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejcb.2026.151565_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The Molecular Taxonomy of Primary Prostate Cancer.","volume":"163","author":"Cancer Genome Atlas Research","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat. Cell. Biol."},{"issue":"22","key":"10.1016\/j.ejcb.2026.151565_bib13","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for Metastatic Castration-Resistant Prostate Cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejcb.2026.151565_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.ejcb.2026.151565_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","article-title":"Loss and revival of androgen receptor signaling in advanced prostate cancer","volume":"40","author":"Formaggio","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejcb.2026.151565_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"issue":"7406","key":"10.1016\/j.ejcb.2026.151565_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejcb.2026.151565_bib19","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/s41418-021-00824-w","article-title":"TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer","volume":"28","author":"Gui","year":"2021","journal-title":"Cell. Death Differ."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ejcb.2026.151565_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng.2862","article-title":"A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding","volume":"46","author":"Huang","year":"2014","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ejcb.2026.151565_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nm.4053","article-title":"Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer","volume":"22","author":"Kumar","year":"2016","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.ejcb.2026.151565_bib23","doi-asserted-by":"crossref","first-page":"T95","DOI":"10.1530\/ERC-21-0149","article-title":"The tumor microenvironment and immune responses in prostate cancer patients","volume":"28","author":"Kwon","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"issue":"7801","key":"10.1016\/j.ejcb.2026.151565_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","article-title":"A genomic and epigenomic atlas of prostate cancer in Asian populations","volume":"580","author":"Li","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejcb.2026.151565_bib25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.18632\/oncotarget.6370","article-title":"Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer","volume":"7","author":"Meller","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2022.01.008","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"185","author":"Morad","year":"2022","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.ejcb.2026.151565_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.320663.118","article-title":"Helix-loop-helix proteins and the advent of cellular diversity: 30 years of discovery","volume":"33","author":"Murre","year":"2019","journal-title":"Genes. Dev."},{"issue":"2","key":"10.1016\/j.ejcb.2026.151565_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1158\/1541-7786.MCR-05-0098","article-title":"Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer","volume":"4","author":"Nanni","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.ejcb.2026.151565_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050162","article-title":"Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone","volume":"21","author":"Owen","year":"2020","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.ejcb.2026.151565_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cr.2012.30","article-title":"RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings","volume":"22","author":"Ren","year":"2012","journal-title":"Cell. Res."},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.eururo.2017.08.027","article-title":"Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression","volume":"73","author":"Ren","year":"2018","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s42003-022-03843-6","article-title":"Reversible epigenetic alterations regulate class I HLA loss in prostate cancer","volume":"5","author":"Rodems","year":"2022","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejcb.2026.151565_bib35","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1073\/pnas.0808866106","article-title":"E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors","volume":"106","author":"Semerad","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1364828","article-title":"PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?","volume":"7","author":"Simon","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejcb.2026.151565_bib38","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20101785","article-title":"Genomic loss of the putative tumor suppressor gene E2A in human lymphoma","volume":"208","author":"Steininger","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","article-title":"How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer","volume":"24","author":"Stultz","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"7","key":"10.1016\/j.ejcb.2026.151565_bib40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41388-018-0488-5","article-title":"A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome","volume":"38","author":"Stylianou","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell."},{"issue":"4","key":"10.1016\/j.ejcb.2026.151565_bib42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/0008-5472.CAN-16-1589","article-title":"RB Loss Promotes Prostate Cancer Metastasis","volume":"77","author":"Thangavel","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.ejcb.2026.151565_bib44","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1073\/pnas.87.12.4722","article-title":"Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains","volume":"87","author":"Voronova","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ejcb.2026.151565_bib45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/0008-5472.CAN-07-2608","article-title":"Tumor immunobiological differences in prostate cancer between African-American and European-American men","volume":"68","author":"Wallace","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejcb.2026.151565_bib46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejcb.2026.151565_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2016.09.011","article-title":"Structural characterization of mammalian bHLH-PAS transcription factors","volume":"43","author":"Wu","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"17-18","key":"10.1016\/j.ejcb.2026.151565_bib48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1101\/gad.316984.118","article-title":"TCF3 alternative splicing controlled by hnRNP H\/F regulates E-cadherin expression and hESC pluripotency","volume":"32","author":"Yamazaki","year":"2018","journal-title":"Genes. Dev."},{"issue":"11","key":"10.1016\/j.ejcb.2026.151565_bib49","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1261\/rna.072298.119","article-title":"TCF3 mutually exclusive alternative splicing is controlled by long-range cooperative actions between hnRNPH1 and PTBP1","volume":"25","author":"Yamazaki","year":"2019","journal-title":"RNA"},{"issue":"9","key":"10.1016\/j.ejcb.2026.151565_bib50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933526000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933526000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:38:05Z","timestamp":1790829485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171933526000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0171933526000361"],"URL":"https:\/\/doi.org\/10.1016\/j.ejcb.2026.151565","relation":{},"ISSN":["0171-9335"],"issn-type":[{"value":"0171-9335","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TCF3 safeguards tumor-intrinsic interferon competence to restrain prostate cancer progression and immune escape","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejcb.2026.151565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151565"}}